)
Visual
test
Fresenius
Fresenius (FRE) investor relations material
Fresenius 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026
Industry trends and company positioning
Healthcare is increasingly vital for global resilience, wealth, and security, with longevity and chronic disease trends driving demand and workforce challenges emerging.
The company is positioned across hospitals, pharmaceuticals, medical technology, and innovative services, covering the full healthcare spectrum.
Inefficiencies in Western healthcare systems present opportunities, especially for cost-effective generics and solutions.
The company plays a key role in addressing U.S. drug shortages, especially with IV generics.
All business segments are in growth areas with strong market positions and organic growth potential.
Portfolio focus and financial performance
Over the past three years, the portfolio was streamlined, focusing on core businesses and divesting non-core assets.
Operating margins and EPS have improved, with net debt to EBITDA reduced to target levels, enabling disciplined capital allocation.
Growth vectors such as MedTech, nutrition, and biosimilars have driven incremental innovation and financial performance.
Management incentives now align with share price performance and equity ownership.
The company is in a 'rejuvenate phase,' focusing on scaling core businesses and executing with new leadership.
Business segment highlights
IV generics and fluids remain essential, resilient, and cash-generative, with a broad U.S. portfolio and local manufacturing supporting volume growth.
Nutrition business is innovation-driven, expanding with new formulas and segments, and showing strong growth despite market pressures.
MedTech growth is fueled by new products like the Ivenix smart infusion pump and software innovations, with successful rollout and cost reductions.
Biopharma (biosimilars) is expected to double revenues by 2030, with margins reaching 20%, driven by new molecules and commercial models.
Capital deployment priorities for scaling platforms?
Is 2030 biosimilar margin target conservative?
German hospital margin outlook for 2026?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebMGL
Strong revenue growth offset by lower margins and profit; interim dividend declared. - 7 FebPGIL
Strong revenue and margin growth, with India set for further expansion and upgraded ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights.
Next Fresenius earnings date
Q4 202525 Feb, 2026
Fresenius
Next Fresenius earnings date
Q4 202525 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Fresenius SE & Co. KGaA operates as a health care group that provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company offers infusion therapies and clinical nutrition products; medical devices and services comprising renal, hospital, and surgical products; dialysis services through a network of independent subsidiary Fresenius Medical Care clinics; assistance with the promotion of healthy lifestyles, disease prevention services, and homecare services; hospital management and care management as well as hospital construction planning and financing services; and consulting, engineering, environmental, healthcare infrastructure development, project logistics/supply chain management/product testing, rail vehicle maintenance/IT security infrastructure support/e-learning platform operations in Germany.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage